# Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)

> **NCT00406094** · PHASE4 · UNKNOWN · sponsor: **Bernstein, Jonathan A., M.D.** · enrollment: 6 (estimated)

## Conditions studied

- Rhinitis

## Interventions

- **DRUG:** montelukast
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00406094
- **Lead sponsor:** Bernstein, Jonathan A., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2009-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406094, "Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00406094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*